QMed Inc

QMed — Investor Presentation (March 2007)

21 slides from QMed's investor presentation, Mar 15, 2007

  1. Slide 1: QMed, Inc. Managing the Chronically Ill

    Slide 1: QMed, Inc. Managing the Chronically Ill

    QMed, Inc. Managing the Chronically Ill

  2. Slide 2: Forward Looking Statements

    Slide 2: Forward Looking Statements

    This presentation contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement c

  3. Slide 3: Guidance for SNP Revenue

    Slide 3: Guidance for SNP Revenue

    Our guidance for 2007 is $38.5 - $44 Million revenue for New Jersey and South Dakota chronics alone (~3%) Fundamentals South Dakota New Jersey Population 112,994 276,796 Chronic Population 19,840 68,100 % Chronics 17.6% 24.6% Total All Population Costs $705,082,560 $2,922,965,760 Total Chronic Costs

  4. Slide 4: Medicare Special Needs Plans

    Slide 4: Medicare Special Needs Plans

    Medicare Modernization Act established Special Needs Plans for Duals, Institutionalized, and Chronically Ill individuals who have special needs QMedCare is primarily oriented to SNPs for those with chronic conditions e.g CAD, CHF, Stroke Risk adjusted payments (RAPS) from Medicare These payments can

  5. Slide 5: Illustrative Risk Score Levels

    Slide 5: Illustrative Risk Score Levels

    1.00 0.92 1.90 1.29 Illustrative Risk Score Levels Average Medicare Non-Institutionalized/Non-Medicaid Institutionalized Dual Eligible (Medicare/Medicaid) Nationwide Risk Score Eligibility Category

  6. Slide 6: Political & Regulatory Outlook

    Slide 6: Political & Regulatory Outlook

    We believe the outlook for SNPs continues to improve We stay active on Capitol Hill and at CMS CMS marketing regulations are evolving to assist SNPs All understand that chronics spend most Medicare funds Medicare can save by removing artificial overpayment to MA with healthier members PFFS plans are

  7. Slide 7: Why QMed’s SNPs are Special

    Slide 7: Why QMed’s SNPs are Special

    1.0 or less 1.2 - 2.3 $350+ (NJ + SD) $125 (NJ) $101 (SD) Non-engaging Fully Engaging No coverage or Generics Only Brand and Generic Chronic Avoidance Chronically Ill Discounted Contracts Quality Of Care Why QMed’s SNPs are Special RAPs Patient Value Proposition Provider Interest Part D and Donut ho

  8. Slide 8: QMed Background for SNP Success

    Slide 8: QMed Background for SNP Success

    Successful Medical & Disease Management FFS and capitated markets Seniors and commercial members with cardiovascular disease Demonstration projects with CMS IT systems include electronic medical records, expert system analytics, physician engagement, detailed reporting QMed Background for SNP Succes

  9. Slide 9: QMed Background for SNP Success

    Slide 9: QMed Background for SNP Success

    Our Medicare SNPs are based on this expertise We are a “Care Model”, not a “Contracting Model” Plan We manage the bottom line Clinical algorithms boost best practice medicine C3 – Community Coordinated Care for patients linked to all providers Quality reporting leading to enhanced physician support

  10. Slide 10: Fundamental Development

    Slide 10: Fundamental Development

    Our care model addresses core medical system issues of quality and measurement by reconfiguring healthcare for chronically ill Medicare beneficiaries for the 21 st Century. Fundamental Development

  11. Slide 11: Early Lessons

    Slide 11: Early Lessons

    Price and design for seniors post Part D Understand CMS marketing guidelines Engage the selling broker community Engage physicians and hospitals Execute above peers Enrollment Manage RAPS for Top Line Medical Management for the bottom line Early Lessons

  12. Slide 12: Keys to Enrollment – Recruitment Strategy

    Slide 12: Keys to Enrollment – Recruitment Strategy

    Meet the needs of hospitals Meet the needs of physicians Meet the needs of patients Market, market, market – intelligence based on regional and local dynamics Keys to Enrollment – Recruitment Strategy

  13. Slide 13: Patient Value Proposition

    Slide 13: Patient Value Proposition

    Cost of Coverage Comparison HLP (QMed) Wellmark HeartLine Plus $101.00 Supplemental Premium included $140.00 Part D thru donut hole (option 3) included $110.30 Total Cost of Coverage $101.00 $250.30 Monthly Savings 59.6% $149.30 Cost of Coverage Comparison QMed AARP QMedCare $125.00 Approx. Supplime

  14. Slide 14: Comprehensive Marketing

    Slide 14: Comprehensive Marketing

    Strategic relationships with more than 300 senior products brokers Hospital systems endorse the program to physicians Physicians can now tell their patients about our SNP health, drug and cost benefits Understand local market dynamics Easy and concise messaging to Medicare Beneficiaries Comprehensiv

  15. Slide 15: So, How are we doing…?

    Slide 15: So, How are we doing…?

    Reconciled as of 9/30/06 So, How are we doing…?

  16. Slide 16: So, How are we doing …?

    Slide 16: So, How are we doing …?

    So, How are we doing …?

  17. Slide 17: Predicted Observed

    Slide 17: Predicted Observed

    25 1.5 05 2.33 88 164 | 2 Predicted Observed Regeeess 83 82 81 80 Sian soore WLR

  18. Slide 18: Unique Infrastructure

    Slide 18: Unique Infrastructure

    – Proactively identifying Gaps to concentrate care efforts for members cost effectively – Chart review identification for proper reimbursement for managing risk underwriting, maintain revenue with balanced budget act – Enhanced our electronic medical record system to capture more comprehensive infor

  19. Slide 19: Investment Perspective

    Slide 19: Investment Perspective

    Right Product – Right Time – Right Price – Right Care Model Industry leading IT backbone Market is Large 90k targets of opportunity = $1.8 BILLION (NJ +SD) Dual SNP in May 2007 in SD Expansion probable in 2008 Experienced Motivated Management Team SNP 2007 Guidance $38.5 - $44 Million Investment Per

  20. Slide 20: Investment Perspective

    Slide 20: Investment Perspective

    Our care model addresses core medical system issues of quality and measurement by reconfiguring healthcare for chronically ill Medicare beneficiaries for the 21 st Century. We will continue to deliver growth and performance in the fastest growing most important segment in healthcare. Investment Pers

  21. Slide 21: QMed Inc. Managing the Chronically Ill

    Slide 21: QMed Inc. Managing the Chronically Ill

    QMed Inc. Managing the Chronically Ill

Source: SEC EDGAR · 8-K filed Mar 15, 2007

More decks from QMed Inc